Headquartered in Brentwood, TN·Fiscal year ends December·NASDAQ: CYRX·cryoportinc.com
About Cryoport
Cryoport, Inc. (NASDAQ: CYRX) is a global provider of integrated temperature-controlled supply chain solutions for the life sciences industry, with a particular emphasis on regenerative medicine, including cell and gene therapies. The company serves biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), developers, and researchers. Its platform encompasses the Cryoportal logistics management system, advanced temperature-controlled packaging, informatics, specialized BioLogistics, BioStorage, BioServices, cryopreservation services (IntegriCell), and cryogenic systems manufactured under the MVE Biological Solutions brand. The company operates through two primary segments: Life Sciences Services (comprising BioLogistics Solutions and BioStorage/BioServices) and Life Sciences Products. As of June 30, 2026, Cryoport supported 779 global clinical trials and 22 commercially approved cell and gene therapies, maintaining operations across the Americas, EMEA, and APAC regions. The company divested its CRYOPDP specialty courier business to DHL Group in June 2025. Updated
Friday's top analyst upgrades and downgrades included Adobe, American Airlines, BorgWarner, Coherent, Freeport-McMoRan, SL Green Realty, Snowflake, Southwest Airlines, Wendy’s and Wolfspeed.
Friday's top analyst upgrades and downgrades included AppLovin, Crown Castle, GoodRx, Global Payments, Monster Beverage, Penn Entertainment, Plug Power, Roblox, Southern Company and Wynn Resorts.
Friday's top analyst upgrades and downgrades included Alibaba, Chewy, Danaher, Energy Transfer, LyondellBasell, LiveNation, Salesforce, Seagate, Splunk and Textron.
Monday's top analyst upgrades and downgrades included Abercrombie & Fitch, Cabot Oil, Dollar General, L Brands, MGM Resorts, ViacomCBS and Unity Software.
Tuesday's top analyst upgrades and downgrades included Akamai Technologies, Beyond Meat, Broadcom, Dow, Morgan Stanley, Plug Power, TripAdvisor and Zoom Video Communications.
Friday's top analyst upgrades and downgrades included Alteryx, Booking, CarGurus, Datadog, FedEx, First Solar, Uber Technologies, Vonage, Yeti and Zillow.
Cryoport, Inc. (NASDAQ: CYRX) is a global provider of integrated temperature-controlled supply chain solutions for the life sciences industry, with a particular emphasis on regenerative medicine, including cell and gene therapies.
What is the CYRX stock price target?
The Wall Street consensus 12-month price target for CYRX is $19.67.